John’s Journey with R/R MM

Now Viewing

EP: 1.John’s Journey with R/R MM

EP: 2.MonumenTAL: Key Efficacy Outcomes

EP: 3.Implications of Talquetamab on the Current Treatment Landscape for R/R MM

EP: 4.Bispecifics in R/R MM: Selecting the Best Bispecific and Optimal Sequencing Strategies

EP: 5.Eva’s Treatment Journey With R/R MM

EP: 6.MagnestisMM: Key Efficacy Data and its Clinical Implications

EP: 7.Elranatamab: Real-World Experience and Sequencing

EP: 8.Future of R/R MM: Emerging Agents

This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of patients with R/R MM as seen in clinical practice. The hypothetical case was co-developed by staff Medical Writers with Cancer Network/ONN.

Patient case specs:

• 68-year-old male, construction worker, diagnosed with multiple myeloma 10 years ago
• Initial treatment: bortezomib, lenalidomide, and dexamethasone, daratumumab, pomalidomide, dexamethasone, carfilzomib, elotuzumab and BCMA directed CAR T therapy
• History of hypertension, respiratory infections (2 episodes of pneumonia and multiple episodes of bronchitis), type 2 diabetes – all have been managed well, active lifestyle, strong support system
• Receives talquetamab